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Summary
Understanding the complexity of aging is of utmost importance.
This can now be addressed by the novel and powerful approach
of metabolomics. However, to date, only a few metabolic studies
based on large samples are available. Here, we provide novel and
speciﬁc information on age-related metabolite concentration
changes in human homeostasis. We report results from two popu-
lation-based studies: the KORA F4 study from Germany as a
discovery cohort, with 1038 female and 1124 male participants
(32–81 years), and the TwinsUK study as replication, with 724
female participants. Targeted metabolomics of fasting serum
samples quantiﬁed 131 metabolites by FIA-MS⁄MS. Among these,
71⁄34 metabolites were signiﬁcantly associated with age in
women⁄men (BMI adjusted). We further identiﬁed a set of 13
independent metabolites in women (with P values ranging from
4.6 · 10
)04 to 7.8 · 10
)42, acorr = 0.004). Eleven of these 13 metab-
olites were replicated in the TwinsUK study, including seven
metabolite concentrations that increased with age (C0, C10:1,
C12:1, C18:1, SM C16:1, SM C18:1, and PC aa C28:1), while histidine
decreased. These results indicate that metabolic proﬁles are age
dependent and might reﬂect different aging processes, such as
incomplete mitochondrial fatty acid oxidation. The use of meta-
bolomics will increase our understanding of aging networks and
may lead to discoveries that help enhance healthy aging.
Key words: age; aging; epidemiology; metabolomics; popula-
tion-based study.
Introduction
Life expectancy in humans has dramatically increased throughout the
world (Ferrucci et al., 2008). This process entails great challenges for
world population in terms of health and economics, and complex social
issues emerge, in particular for the future of healthcare systems, as aging
is often accompanied by disabilities and diseases such as cardiovascular
diseases, chronic lower respiratory tract disease, Alzheimer’s disease,
chronic joint symptoms, arthritis, and diabetes (Butler et al., 2008;
Wijsman et al., 2011). Thus, understanding the physiology of aging is of
tremendous importance to allow populations to grow old, disease-free
and with a good quality of life.
Aging is a very complex process because many transformations happen
to the human organisms that affect all levels, from organ systems to cell
organelles, and lead to a wide variety of altered functions. However, this
process is incompletely understood. Genetic and environmental inﬂu-
ences seem to be involved, but other approaches and insights are needed
(Karasik et al., 2005; Piper & Bartke, 2008; Kerber et al., 2009; Deelen
et al., 2011). Popular theoriesof aging include those implicating free radi-
cals, accumulation of glycated proteins (AGEs), involvement of chronic
low-grade inﬂammation, altered action of several hormones or chromo-
some telomere shortening (Szibor & Holtz, 2003; Franceschi et al., 2007;
Yan et al., 2007; Jiang et al., 2008; Simm et al., 2008; Perheentupa &
Huhtaniemi, 2009). Nonetheless, the largest volume of knowledge stems
from non-human studies. Based on genetic studies in animal models,
there are several complex pathways known to be involved in aging mech-
anisms that also are clearly linked to metabolism (Toth & Tchernof, 2000;
Dennis et al., 2009; Feltes et al., 2011; Partridge et al., 2011).
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lMetabolomics is a key technology of modern systems biology that
focuses on obtaining an integral depiction of the current metabolic status
of an organism, associated with physiological and pathophysiological
processes (Psychogios et al., 2011). Numerous small molecules are mea-
sured that can be both endogenous and exogenous. These ideally repre-
sent the whole range of intermediate metabolic pathways and may serve
as biomarkers, indicating distinct physiological and⁄or pathophysiological
states of an organism (He et al., 2012). Metabolomics is therefore a valu-
able tool for investigating in a single approach all the various ways in
which metabolism is inﬂuenced, and then linking these inﬂuences to the
phenotypic outcome of interest, thus a very promising tool for capturing
the complexity of the aging process.
Only a few aging studies with metabolomics analyses have been con-
ducted in animal models (in rats, mice and dogs) (Williams et al., 2005;
Wang et al., 2007; Nevedomskaya et al., 2010). The very few published
results on aging in adult humans have been small. A study of 269 individ-
uals (both men and women) analyzed the human plasma metabolome
with age using NMR and thus obtaining a very different set of metabolites
to the current study (Lawton et al., 2008; Ores ˇic ˇ, 2009). Nikkila ¨ and col-
leagues performed a metabolomics study on early childhood, following
59 children from birth to an age of 4 years, and identiﬁed previously
unknown metabolic changes with age (Nikkila et al., 2008).
The objectives of the current study were to characterize the metabolic
proﬁle of a large group of subjects with a wide age range (32–81 years)
and identify metabolites relates to chronological age independent of BMI.
Such metabolites may subsequently be investigated in future studies
to establish whether they associate with health conditions and aging
mechanisms.
Results
Study population
Individuals without metabolic diseases (e.g. hypertension, type 2 diabetes
and obesity) were used in both studies of the Cooperative Health
Research in the Region of Augsburg () (Holle et al., 2005; Wichmann
et al., 2005) and the UK Adult Twin Registry (TwinsUK) (Spector &
Williams, 2006; Moayyeri et al., 2012). KORA F4 sample involved 1038
women and 1124 men, aged 32–81 years (Table 1). Women and men of
the KORA participants were about the same average age (54 years old)
and had comparable mean BMIs (around 26 kg m
)2). The TwinsUK
contained 742 women, aged 19–82 years, with a mean age of 58 years
and BMI of about 26 kg m
)2. Comparing the discovery KORA women
with the replication TwinsUK individuals, KORA women are about 4 years
younger and have a slightly higher BMI (Table 1).
Serum concentrations of 163 metabolites were measured in all fasting
participants; the 163 metabolites and their characteristics are summa-
rized in Table S1 (Supporting information).
Discovery of age-associated metabolites: general analyses
procedure
Owing to prior results from KORA F4, which showed strong metabolic
differences between women and men (Mittelstrass et al., 2011), we
conducted strictly sex-separated analyses. Furthermore, we found that
the BMI was signiﬁcantly correlated with both age (Pearson’s r = 0.26,
P = 2.2 · 10
)16) and metabolite concentrations (Table S1) in KORA F4.
To investigate the ‘true’ age-related metabolites, BMI was adjusted in
subsequent analyses, and residuals of metabolite concentrations from
linear regression against BMI were used in the graphs. We ﬁrst plotted
heat maps of mean residuals for 131 metabolites for each year of age as
an explorative tool. Second, we used linear regression models for each
metabolite at individual level to identify age-related metabolites. More-
over, as some of these metabolites correlated with each other, especially
for the same classes (Fig. S1), we employed two additional statistical
methods, the nonparametric random forest and the parametric stepwise
selection methods, to identify unique and independent biomarker
candidates. Finally, the set of age-related metabolites were replicated in
the TwinsUK study. Smoother plots of this subset of metabolites were
displayed to characterize age-associated changes regarding metabolite
concentrations (Figs S3–S5).
Heat map of KORA F4 revealed association between age
and metabolite
We display heat maps of normalized mean metabolite residuals for each
year of age in both women and men. The resulting heat map for women
displayed a clear increase in metabolite concentrations with respect to
age in KORA F4, in particular with most acylcarnitines (ACs) and diacyl
phosphatidylcholines (PC aa), while others showed gradual decreases
with age, for example, for most amino acids (AAs) (Fig. 1). A similar trend
for most ACs and AAs were also observed in the heat map for men; how-
ever, most of the Lyso PCs decreased with age in men. In general, the
results of heat maps of women and men showed different patterns of
changes and clusters (the heat map result of men is shown in Fig. S2).
Identiﬁcation of a metabolite set for age
We performed multiple linear regression analysis between metabolite
concentrations and age with BMI as covariate. In the discovery cohort, we
found 71 metabolite concentrations in women and 34 metabolites in
men that were signiﬁcantly associated with age (P values < 3.8 · 10
)4).
As some of these metabolites are expected to correlate with each other,
we employed two additional statistical methods (the nonparametric ran-
dom forest and the parametric stepwise selection, see below) to identify
independent biomarker candidates. Of the 71⁄34 metabolites, 13⁄12
were found to contain independent information in women and men,
respectively (mean concentrations, beta and P values for women are
shown in Table 2, and for men in Table S2) (Supporting information). Five
metabolites (C12:1, C18:1, His, Trp, and PC ae C36:1) were found both
in women and men.
Smoother plots were drawn to characterize the trends and courses of
metabolite concentration changes with age in women (Fig. S3) and men
(Fig. S4). The smoothing method was ‘loess’, which is a locally weighted
regression robust against a small fraction of outliers. As already stated for
the heat map, some metabolite concentrations showed increasing, while
some showed decreasing, trends with age, but smoother plots provided
deeper insight. For example, the larger proportion of the identiﬁed
metabolites showed linear associations with age for both women and
Table 1 Population characteristics of KORA F4 and Twins UK
KORA F4 TwinsUK
Males Females Females
N 1124 1038 742
Age (years)† 53.6 ± 12.5 54.1 ± 13.1 57.7 ± 10.6
BMI (kg m
)2)† 25.9 ± 3.9 27.1 ± 3.2 25.6 ± 3.7
†Values of age and BMI are shown mean ± standard deviation (SD).
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961men, with the exception of three metabolites in women (PC ae C42:4, PC
ae 42:5, and PC ae C44:4) and one in men (Gln), which exhibited a
decrease around age of 51.
Replication of the metabolite set in the TwinsUK
For replication purpose, we used an independent sample of 742 women
subjects derived from the TwinsUK cohort, for whom fasting serum
metabolomics data were available. The metabolites showed comparable
mean concentrations in both studies. Among the 13 age-related metabo-
lites found in the KORA study, 11 metabolites were well replicated in the
TwinsUK sample, with P < 0.004 for the signiﬁcance level after adjust-
ment for multiple testing with the Bonferroni correction method
(Table 2), and the effect direction was the same as in the discovery sam-
ple (except for one metabolite, PC ae C36:1), with borderline signiﬁcance
in the TwinsUK sample (P = 2.00 · 10
)03). We also drew smoother plots
for the TwinsUK sample and obtained similar curve shapes (with the
exception of PC ae C36:1) (Fig. S5).
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Fig. 1 Heat map of the fold standard deviation changes between ages, and clustering of these changes, over all ages in 1038 women from KORA F4. The heat map shows
changes of x-fold standard deviation from the overall mean concentration for each age year in a color-coded way. Green squares represent a decrease, and red squares an
increase. Gray boxes represent groups of metabolites with similar changes with number of metabolites in parentheses. Metabolite names in red indicate our set of 13
metabolites. AA, amino acid; AC, acylcarnitines; PC aa, phosphatidylcholinediacyl; PC ae, phosphatidylcholine acyl-alkyl; and lyso PC a, lysophosphatidylcholine acyl.
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962Furthermore, we analyzed both study samples in a meta-analysis,
which virtually gave the same results as in the KORA female sample alone.
All 13 metabolites of the marker set were signiﬁcant, with P values
ranging from 5.18 · 10
)6 to 3.87 · 10
)32.
Discussion
We found strong associations between age and the human metabolome
and identiﬁed 11 metabolites that associated with age in women in both
discovery and replication cohort. Our ﬁnding of 12 metabolites associated
with age in men was not yet tested for conﬁrmation.
The extent of sexual dimorphism in the metabolome has recently been
shown (Mittelstrass et al., 2011), stressing the need for sex stratiﬁcation.
Even accounting for the lack of a replication sample, the results in men
are less impressive for unclear reasons. Lifestyle and different life experi-
ences probably play prominent roles in this. Nonetheless, ﬁve metabolites
could be identiﬁed in both men and women in the discovery cohort, so
that these may be considered to be metabolites associated with aging in
the population as a whole.
We explored biological alterations that might have led to the observed
changes in metabolite concentrations and could link our observations to
common aging theories. As we had excluded participants with major
metabolic diseases, we assume that our ﬁndings may be representative
for the general aging population.
Phospholipids are major components of cell membranes. Changes in
the cellular membrane that include a G protein coupled receptor may
relate to aging, which affects at least G protein activity, cell morphology,
and cell homeostasis (Naru et al., 2008).A common feature of cellular
senescence is an increased cell surface. Naru et al. (2008) found that
senescent cells had a higher uptake of PC species with long-chain fatty
acid residues. Additionally, the number of special lipid rafts, termed
caveolae, increased with senescence. Presumably, PC species were inte-
grated into caveolae, which contain caveolin-1 as a crucial component
capable of cell cycle suppression at the G0⁄G1 phase. Thus, altered
consumption of phospholipids because of speciﬁc membranaceous
demands could be associated with senescence, possibly involving the
scavenger receptor SR-BI as the major mediator of selective phospholipid
(PC, SM, and PE) uptake from particles as HDL and LDL (Engelmann &
Wiedmann, 2010),
Sphingomyelins are further important components of cell membranes,
especially neuronal cells, as they inﬂuence membrane ﬂuidity and can
promote signal transduction. While both Ichi et al. (2009) and Corre et al.
(2010) reported the connection between oxidative stress and sphingomy-
elin metabolism, in their studies, oxidative stress was shown to accelerate
degradation of sphingomyelins to ceramide, which would be inconsistent
with our observation that elderly subjects had elevated SM levels. How-
ever, another study identiﬁed cells that had adapted to chronic oxidative
stress by altering sphingomyelin metabolism and making major changes
in membrane composition, leading to stabilization (Clement et al., 2009).
The observed SM level elevations might indicate that aging humans have
effective mechanisms to protect cells from oxidative stress, accompanied
by changes in SM metabolism and incorporation of SM into cell
membranes.
Elevated serum levels of acylcarnitines could be due to different
underlying causes. AC species are found as a consequence of incom-
pletely oxidized fatty acids because of an excess of beta oxidation
capacity and related pathways (i.e. higher rate of substrate use than
energy demand, with accumulated acyl-CoA converted to AC that
then exits cells and tissues), but also as a consequence of oxidative
stress (Noland et al., 2009). Acylcarnitines in turn show up in the
blood. A recent rodent study suggested increased AC levels in blood
could be healthy (Noland et al., 2009). In the study, Wistar rats main-
tained on a high-fat diet exhibited diminished carnitine and increased
AC levels in skeletal muscle cells because of perturbations in mito-
chondrial fuel utilization, for example, they had incomplete fatty acid
oxidation. Supplemented carnitine led to AC efﬂux, which in turn
showed up in blood accompanied by improved metabolism and glu-
cose tolerance. Thus, the carnitine shuttle system is considered to be a
prominent factor in maintaining mitochondrial performance and
glucose homeostasis.
Table 2 Potential biomarkers for aging in women from KORA F4 and TwinsUK
Marker
Discovery sample Replication sample
KORA F4 females TwinsUK females Meta-analysis
Mean† ± SD b (SE) P value§ Mean ± SD b (SE) P value§ b (SE) P value§
C0 32.93 ± 6.79 0.45 (0.05) 2.77E)19 38.29 ± 9.38 0.26 (0.04) 5.30E)10– 0.33 (0.03) 1.04E)26
C10:1 0.15 ± 0.05 79.67 (6.69) 7.96E)31 0.19 ± 0.06 24.15 (6.38) 7.53E)05– 50.59 (4.62) 6.08E)28
C12:1 0.14 ± 0.04 105.20 (8.06) 2.93E)36 0.17 ± 0.05 28.64 (8.60) 1.00E)03– 69.4 (5.88) 3.87E)32
C18:1 0.12 ± 0.03 118.02 (10.86) 3.65E)26 0.19 ± 0.05 33.09 (7.51) 5.40E)06– 60.57 (6.18) 1.07E)22
His 97.41 ± 13.67 )0.18 (0.02) 3.15E)13 98.22 ± 28.93 )0.10 (0.02) 2.90E)06– )0.14 (0.01) 4.18E)23
Trp 80.2 ± 8.85 )0.24 (0.04) 1.29E)10 86.66 ± 16.63 )0.035 (0.03) 0.18 )0.11 (0.02) 5.81E)06
PC aa C28:1 3.56 ± 0.89 4.65 (0.36) 2.10E)35 4.17 ± 1.27 1.54 (0.33) 2.10E)06– 2.96 (0.24) 4.59E)34
PC ae C36:1 8.94 ± 2.05 2.15 (0.15) 7.75E)42 12.14 ± 5.23 )0.31 (0.16) 2.00E)03 1 (0.11) 6.75E)20
PC ae C42:4 1.08 ± 0.25 )6.44 (1.39) 4.25E)06 1.18 ± 0.46 )5.84 (1.13) 1.20E)07– )6.08 (0.88) 4.13E)12
PC ae C42:5 2.49 ± 0.50 )2.42 (0.69) 4.57E)04 2.71 ± 0.98 )2.57 (0.52) 3.20E)07– )2.52 (0.42) 1.38E)09
PC ae C44:4 0.46 ± 0.11 )15.23 (3.05) 6.76E)07 0.51 ± 0.18 )10.56 (2.52) 1.00E)05– )12.45 (1.94) 1.45E)10
SM C16:1 16.80 ± 2.97 1.27 (0.11) 4.89E)28 19.58 ± 4.79 0.38 (0.09) 1.00E)05– 0.74 (0.07) 3.74E)26
SM C18:1 11.96 ± 2.56 1.32 (0.13) 3.36E)22 12.38 ± 3.50 0.42 (0.12) 1.00E)03– 0.33 (0.03) 1.04E)26
†Mean concentration in lM from serum.
ß estimate represents changes per year of age, adjusted for BMI.
§Corrected signiﬁcance level of acorr = 0.004 (correction for 13 tests according to Bonferroni method).
–Replication succeeded for these markers.
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963The observed higher levels of AC with advanced age might indicate
that the aging processes counteract oxidative damage from the
mitochondria via the carnitine-acylcarnitine shuttle.
The metabolic fate of the amino acid histidine has two possible routes.
Its presence in blood at higher ages could indicate an advanced tissue
demand. The ﬁrst histidine-consuming pathway is its metabolism to the
biogenic amine histamine by a decarboxylation step. Histamine is involved
in local immune responses and can act as neurotransmitter. However, to
our knowledge, an association between histidine or histamine and
immunosenescence has not been reported so far. The second metabolic
pathway that consumes histidine produces carnosine. This dipeptide from
beta-alanine and L-histidine is found in virtually all tissues, in particular in
skeletal muscle cells and different brain cells (Derave et al., 2010). Owing
to its antioxidant characteristics, carnosine is considered to be a natural
anti-aging substance capable of suppressing oxidative damage, glycation
of proteins, and scavenging toxic age-related molecules (Hipkiss, 2010).
For instance, carnosine was shown to capture lipoxidation products and
prevent protein cross-linking (Zhu et al., 2009). Assuming that histidine
levels are lower owing to its consumption by carnosine biosynthesis with
advancing age, decreased histidine in our study might reﬂect a response
to oxidative stress.
Aging is understood as a continuous and dynamic remodeling
process of the human organism accompanied by numerous losses and
gains on different levels, including intermediate metabolism and cell
function (Barbieri et al., 2009). Our results of a large number of age-
associated metabolites and the replicated set of 11 most representative
ones might reﬂect these processes and allow us to draw a more integral
picture of the aging organism. Overall, we observed age-dependent dif-
ferences in PC, SM, AC, and AA levels that might be linked to altered
cell membrane composition, mitochondrial metabolism, and counteract-
ing oxidative stress.
While the present study was large in participant number and metaboli-
cally well characterized, it should be noted that metabolite proﬁles were
related to chronological not physiological age and that only a cross-sec-
tional study design was used. It is also not yet known whether the
changes in the 11 conﬁrmed metabolites represent neutral changes with
age, changes causal to physiological aspects of aging or beneﬁcial
responses to damaging agents. Further research on the metabolic
surrounding of the metabolite set could eventually lead to early determi-
nation of a person’s potential for healthy aging at beginning of the
remodeling process.
In summary, we identiﬁed a set of 11 signiﬁcantly associated and repli-
cated markers for age in women using the German KORA and TwinsUK
studies. Literature gives indications that these markers might be linked to
aging processes such as oxidative stress, alterations in cell morphology,
beta oxidation capacity, and vascular function. This study shows the
power of metabolomics to better understand the phenotype of aging in
the human population and to link this knowledge in functional studies to
aging pathways.
Experimental procedures
Sample Source
KORA is a population-based research platform with subsequent follow-
up studies in the ﬁelds of epidemiology, health economics, and health-
care research (Holle et al., 2005; Wichmann et al., 2005). It is based on
interviews and medical and laboratory examinations, as well as biological
samples. Four surveys were conducted with 18 079 participants who live
in the city of Augsburg (Southern Germany) and 16 surrounding towns
and villages. KORA S4 consists of representative samples from 4261 indi-
viduals who live in Augsburg, who were examined during 1999–2001.
During the years 2006–2008, 3080 participants took part in a follow-up
(KORA F4) survey of the one conducted 7 years ago. For all studies, we
obtained written consent from participants and approval from the ethics
committee of the Bavarian medical association.
To avoid the potential inﬂuences from type 2 diabetes, hypertension
and obesity, we excluded a total of 918 subjects from KORA F4 for subse-
quent analyses, resulting in 2162 subjects aged 32–81 years. Among the
excluded were 20 experimental failures, 18 nonfasting subjects, 332 type
2 diabetics, 80 subjects without fasting glucose or 2 h glucose measure-
ment, 77 subjects with systolic blood pressure > 160 mmHg, and 153
subjects with BMI > 35 kg m
)2. Further removals followed during statisti-
cal analyses (n = 239, see statistical section below).
Sampling
Blood was drawn into serum gel tubes in the morning between 8:00 and
10:30 am after a fasting period of at least 8 h. Tubes were gently inverted
twice, followed by 30 min resting at room temperature to obtain com-
plete coagulation. For serum collection, blood was centrifuged at 2750 g
at 15  C for 10 min. Serum was frozen at )80  C until execution of met-
abolic analyses.
Metabolite measurements
The targeted metabolomics approach was based on measurements with
the AbsoluteIDQ
TM p150 kit (BIOCRATES Life Sciences AG, Innsbruck,
Austria), allowing simultaneous quantiﬁcation of 163 metabolites. The
method conforms with FDA-Guidelines ‘Guidance for Industry – Bioana-
lytical Method Validation (May 2001)’, which implies proof of reproduc-
ibility within a given error range. The assay procedures and nomenclature
have been described previously in detail (Zhai et al., 2010; Mittelstrass
et al., 2011; Ro ¨misch-Margl et al., 2011; Yu et al., 2011). Metabolite
measurements were adjusted for batch effect as we have described
previously (Mittelstrass et al., 2011).
To ensure data quality, each metabolite had to meet the three same cri-
teria we used before (Mittelstrass et al., 2011): (i) average value of the
coefﬁcient of variance (CV) for the metabolite in the three QCs should be
smaller than 25%; (ii) 90% of all measured sample concentrations for the
metabolite should be above the limit of detection (LOD); and (iii) the cor-
relation coefﬁcient between two duplicate measurements of the metabo-
lite in 144 re-measured samples should be above 0.5. In total, 131
metabolites passed the three quality controls, and the ﬁnal metabolomics
dataset contained the sum of hexoses (H1), 14 amino acids (AA), 24 acyl-
carnitines (AC), 13 sphingomyelins (SMs), 34 diacyl phosphatidylcholines
(PC aa), 37 acyl-alkyl PCs (PC ae), and eight lyso PCs. Table S1 (Support-
ing information) summarizes the characteristics of all 163 metabolites
measured in KORA F4.
Statistics
Removal of outliers
To detect outliers, concentrations obtained for the remaining 131 metab-
olites were ﬁrst scaled to have a mean of zero and a standard deviation
(SD) of one and projected onto the unit sphere, and Mahalanobis dis-
tances for each individual were then calculated using the Robust principal
components algorithm (Filzmoser et al., 2008) and were calculated sepa-
rately for men and women. For each group, the mean Mahalanobis dis-
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964tance plus three times variance were deﬁned as the cut-off. About 239
individuals whose distances were greater than these cut offs were
identiﬁed as outliers.
Residuals of metabolite concentrations
To avoid the inﬂuence of BMI when plotting the concentration of
metabolites, we used the residuals from the linear regression model
rather than use the absolute concentration. Log-transformed metabo-
lite concentrations were treated as dependent, and the BMI as an
independent, variable in the linear regression model, and the residuals
from the model were used as the residuals for each metabolite
concentrations. Regressions were performed for women and men
separately.
Heat map
Correlations were calculated for each metabolite pairs, and values were
displayed using heat map. For participants with the same age, mean val-
ues were calculated for residuals from linear regression against BMI for
each metabolite. These values were then scaled to a mean of 0 and a
standard deviation of 1, to display a heat map that showed the changes
of the metabolite concentrations with the increase of age; the color
change in the heat map represents the concentration deviation from the
mean value.
Linear regression analysis
Linear regression was applied to model the relationship between age
and the concentration of each metabolite, with BMI used as covari-
ate. Metabolite concentrations were log-transformed to achieve nor-
mality. Regressions were done for men and women separately. To
handle false discovery rates from multiple comparisons, the cut point
for signiﬁcance was calculated according to the Bonferroni correction,
at a level of 3.8 · 10
)4 (for a total use of 131 metabolites at 5%
level).
Smoother plots
Smoother plots were drawn for each metabolite of the set of metabo-
lites with the R function ‘qplot’ (package ‘ggplot2’) using the options
geom = smooth, method = loess, and span = 0.5, producing smoother
plots with locally weighted regression (loess) applying a smoothing
span of 0.5, which results in medium smoothing. The method com-
putes outlier robust locally weighted regression ﬁtted values by ﬁtting
local polynomials, using weights and results in the (loess) curve as
shown in our smoother plots. Further information about the method
has been previously published (Cleveland & Devlin 1988). For better
visualization, plots were truncated to observations between the ﬁrst
and 99th percentiles.
Criteria for metabolite selection
Multivariate linear regression, random forest, and a stepwise selection
of linear regression methods were applied: metabolites were chosen
if they both were signiﬁcant in linear regression for every single
metabolite, adjusting for BMI and also for the top 30 most important
variables in random forest method, in which both the 131 metabo-
lites and BMI were severed as variables. The chosen metabolites with
BMI as co-variable were further selected based on a stepwise selec-
tion of multi-variables linear regression according to the Akaike infor-
mation criterion (AIC) value.
All calculations were done with R statistical platform, version 2.12
(http://www.r-project.org/).
Replication
TwinsUK is a UK-wide twin registry sample of 11 000 adults, founded
in 1993 with the aim to explore the genetic epidemiology of com-
mon adult diseases (Spector & Williams, 2006). The cohort has been
tested to be generalizable to UK population singletons, with no popu-
lation stratiﬁcation for a wide variety of musculoskeletal, CVD, or
metabolic traits (Andrew et al., 2001). Over 7000 twins have
attended detailed clinical examinations, with a wide range of pheno-
types, over the last 18 years. Blood samples were taken after at least
6 h fasting at each visit. Samples were immediately inverted three
times, followed by 40 min resting at 4  C, to obtain complete coagu-
lation. Samples were then centrifuged for 10 min at 1439 g. Serum
was removed from the centrifuged tubes as the top, yellow, clear
layer of liquid. Aliquot in 4 · 1.5 mL skirted microcentrifuge tubes
was then stored in a –45  C freezer until sampling. About 1237 twins
were selected for the targeted metabolomic proﬁling for either osteo-
arthritis or genetic studies. Metabolites were measured using the
same metabolomics platform (Biocrates metabolomic assay kit; BIO-
CRATES Life Sciences AG, Innsbruck, Austria) and following an identi-
cal protocol as for the KORA study, at the Genome Analysis Centre
of the Helmholtz Centre Munich (Zhai et al., 2010). To replicate the
KORA F4 study, data on the 13 age-related metabolites identiﬁed in
the KORA F4 aging study were retrieved, and the association
between age and these 13 serum metabolites were analyzed by
robust regression modeling that takes into account twin relatedness.
Of the data on a total of 1237 individuals with metabolomic data
available, 44 men were excluded. Following the KORA F4 study’s
exclusion criteria, we further excluded 64 individuals with systolic
blood pressure > 160 mmHg, 14 individuals with type 2 diabetes, 45
individuals with BMI > 35 kg m
)2, and 328 individuals for whom no
data for blood pressure, fasting serum glucose levels, or diabetes
diagnosis data were available. A total of 742 female individuals were
included in the ﬁnal analysis.
Meta-analysis
For the meta-analyses of KORA and TwinsUK women, a ﬁxed effects
model was used.
Acknowledgments
We express our appreciation to all KORA and TwinsUK study partici-
pants for donating their blood and time. We thank the ﬁeld staff in
Augsburg conducting the KORA studies. The KORA group consisted
of H.E. Wichmann (speaker), A. Peters, C. Meisinger, T. Illig, R. Holle,
and J. John as well as their co-workers, who were responsible for the
design and conduction of the studies. We thank the staff from the
Institute of Epidemiology and the Helmholtz ZentrumMu ¨nchen, and
the Genome Analysis Center Metabolomics Platform who helped in
the sample logistics, data and straw collection, and metabolomic
measurements, and especially J. Scarpa, K. Sckell, B. Hochstrat, F.
Scharl, N. Lindemann, H. Chavez, and A. Sabunchi. We thank M. Sat-
tler and V. A. Raker for comments and suggestions.
Metabolic proﬁles associated with age, Z. Yu et al.
ª 2012 The Authors
Aging Cell ª 2012 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
965Authors’ contribution
GZ, KS, JA, TDS, TI, and RWS designed the studies; CP, WRM,
and RWS performed the metabolomic measurements; ZY, GZ, PS,
YH, TX, JA, and RWS analyzed the data; PS, MS, ET, CG, JH, AP, JA,
TI, and RWS interpreted the data; PS, GZ, ZY, TDS, and RWS
wrote the manuscript; and all authors commented on and corrected
the manuscript.
Financial competing interests
Part of this project was supported by the German Federal Ministry of
Education and Research (BMBF) by funding the Project ‘SysMBo:
Systems Biology of Metabotypes’ (FKZ: 0315494A), and the project
‘Metabolomics of ageing’ (FKZ: 01DO12030), the German Center
for Diabetes (DZD) and the NGFN. The TwinsUK study was funded by
the Wellcome Trust, European Community’s Seventh Framework
Programme (FP7⁄2007-2013)⁄grant agreement HEALTH-F2-2008-
201865-GEFOS and (FP7⁄2007-2013), and the FP-5 GenomEUtwin
Project (QLG2-CT-2002-01254). The study also receives support
from the Department of Health via the National Institute for Health
Research (NIHR) comprehensive Biomedical Research Centre award
to Guy’s & St Thomas’ NHS Foundation Trust in partnership with
King’s College London. TDS is an NIHR senior Investigator. The fund-
ers had no role in study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
Nonﬁnancial
None.
References
Andrew T, Hart DJ, Snieder H, de Lange M, Spector TD, MacGregor AJ (2001)
Are twins and singletons comparable? A study of disease-related and lifestyle
characteristics in adult women. Twin Res. 4, 464–477.
Barbieri M, Boccardi V, Papa M, Paolisso G (2009) Metabolic journey to healthy
longevity. Horm. Res. 71(Suppl 1), 24–27.
Butler RN, Miller RA, Perry D, Carnes BA, Williams TF, Cassel C, Brody J, Bernard MA,
Partridge L, Kirkwood T, Martin GM, Olshansky SJ (2008) New model of
healthpromotion and disease prevention forthe 21st century. BMJ 337,a399.
Clement AB, Gamerdinger M, Tamboli IY, Lutjohann D, Walter J, Greeve I, Gimpl
G, Behl C (2009) Adaptation of neuronal cells to chronic oxidative stress is
associated with altered cholesterol and sphingolipid homeostasis and lysosomal
function. J. Neurochem. 111, 669–682.
Cleveland WS, Devlin SJ (1988) Locally-weighted regression: an approach to
regression analysis by local ﬁtting. J. Am. Stat. Assoc. 83, 596–610.
Corre I, Niaudet C, Paris F (2010) Plasma membrane signaling induced by ioniz-
ing radiation. Mutat. Res. 704, 61–67.
Deelen J, Beekman M, Uh HW, Helmer Q, Kuningas M, Christiansen L, Kremer
D, van der Breggen R, Suchiman HE, Lakenberg N, van den Akker EB,Passtoors
WM, Tiemeier H, van Heemst D, de Craen AJ, Rivadeneira F, de Geus EJ,
Perola M, van der Ouderaa FJ, Gunn DA, Boomsma DI, Uitterlinden AG,
Christensen K, van Duijn CM, Heijmans BT, Houwing-Duistermaat JJ,
Westendorp RG, Slagboom PE (2011) Genome-wide association study
identiﬁes a single major locus contributing to survival into old age; the APOE
locus revisited. Aging Cell 10, 686–698.
Dennis JW, Nabi IR, Demetriou M (2009) Metabolism, cell surface organization,
and disease. Cell 139, 1229–1241.
Derave W, Everaert I, Beeckman S, Baguet A (2010) Muscle carnosine metabo-
lism and beta-alanine supplementation in relation to exercise and training.
Sports Med. 40, 247–263.
Engelmann B, Wiedmann MK (2010) Cellular phospholipid uptake: ﬂexible paths
to coregulate the functions of intracellular lipids. Biochim. Biophys. Acta 1801,
609–616.
Feltes BC, de Faria Poloni J, Bonatto D (2011) The developmental aging and
origins of health and disease hypotheses explained by different protein
networks. Biogerontology 12, 293–308.
Ferrucci L, Giallauria F, Guralnik JM (2008) Epidemiology of aging. Radiol. Clin.
North Am. 46, 643–652, v.
Filzmoser P, Maronna R, Werner M (2008). Outlier identiﬁcation in high
dimensition. Comput. Stat. Data Anal., 52, 1694ß1711.
Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invi-
dia L, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S (2007) Inﬂam-
maging and anti-inﬂammaging: a systemic perspective on aging and longevity
emerged from studies in humans. Mech. Ageing Dev. 128, 92–105.
He Y, Yu Z, Giegling I, Xie L, Hartmann AM, Prehn C, Adamski J, Kahn R, Li Y,
Illig T, Wang-Sattler R, Rujescu D (2012) Schizophrenia shows a unique
metabolomics signature in plasma. Transl. Psychiatry (in press).
Hipkiss AR (2010) Aging, proteotoxicity, mitochondria, glycation, NAD and
carnosine: possible inter-relationships and resolution of the oxygen paradox.
Front. Aging Neurosci. 2, 10.
Holle R, Happich M, Lowel H, Wichmann HE (2005) KORA – a research platform
for population based health research. Gesundheitswesen 67, S19–S25.
Ichi I, Kamikawa C, Nakagawa T, Kobayashi K, Kataoka R, Nagata E, Kitamura
Y, Nakazaki C, Matsura T, Kojo S (2009) Neutral sphingomyelinase-induced
ceramide accumulation by oxidative stress during carbon tetrachloride
intoxication. Toxicology 261, 33–40.
Jiang H, Schiffer E, Song Z, Wang J, Zurbig P, Thedieck K, Moes S, Bantel H, Saal
N, Jantos J, Brecht M, Jeno P, Hall MN, Hager K, Manns MP, Hecker H, Ganser
A, Dohner K, Bartke A, Meissner C, Mischak H, Ju Z, Rudolph KL (2008)
Proteins induced by telomere dysfunction and DNA damage represent biomar-
kers of human aging and disease. Proc. Natl. Acad. Sci. USA 105, 11299–
11304.
Karasik D, Demissie S, Cupples LA, Kiel DP (2005) Disentangling the genetic
determinants of human aging: biological age as an alternative to the use of
survival measures. J. Gerontol. A Biol. Sci. Med. Sci. 60, 574–587.
Kerber RA, O’Brien E, Cawthon RM (2009) Gene expression proﬁles associated
with aging and mortality in humans. Aging Cell 8, 239–250.
Lawton KA, Berger A, Mitchell M, Milgram KE, Evans AM, Guo L, Hanson RW,
Kalhan SC, Ryals JA, Milburn MV (2008) Analysis of the adult human plasma
metabolome. Pharmacogenomics 9, 383–397.
Mittelstrass K, Ried JS, Yu Z, Krumsiek J, Gieger C, Prehn C, Roemisch-Margl W,
Polonikov A, Peters A, Theis FJ, Meitinger T, Kronenberg F, Weidinger S, Wich-
mann HE, Suhre K, Wang-Sattler R, Adamski J, Illig T (2011) Discovery of sex-
ual dimorphisms in metabolic and genetic biomarkers. PLoS Genet. 7,
e1002215.
Moayyeri A, Hammond CJ, Valdes AM, Spector TD (2012) Cohort proﬁle: Twin-
sUK and Healthy Ageing Twin Study. Int. J. Epidemiol.
Naru E, Takanezawa Y, Kobayashi M, Misaki Y, Kaji K, Arakane K (2008)
Increased levels of a particular phosphatidylcholine species in senescent human
dermal ﬁbroblasts in vitro. Hum. Cell 21, 70–78.
Nevedomskaya E, Meissner A, Goraler S, de Waard M, Ridwan Y, Zondag G, van
der Pluijm I, Deelder AM, Mayboroda OA (2010) Metabolic proﬁling of accel-
erated aging ERCC1 d ⁄ - mice. J. Proteome Res. 9, 3680–3687.
Nikkila J, Sysi-Aho M, Ermolov A, Seppanen-Laakso T, Simell O, Kaski S, Oresic
M (2008) Gender-dependent progression of systemic metabolic states in early
childhood. Mol. Syst. Biol. 4, 197.
Noland RC, Koves TR, Seiler SE, Lum H, Lust RM, Ilkayeva O, Stevens RD,
Hegardt FG, Muoio DM (2009) Carnitine insufﬁciency caused by aging and
overnutrition compromises mitochondrial performance and metabolic control.
J. Biol. Chem. 284, 22840–22852.
Ores ˇic ˇ M (2009) Metabolomics, a novel tool for studies of nutrition, metabolism
and lipid dysfunction. Nutr. Metab. Cardiovasc. Dis. 19, 816–824.
Partridge L, Thornton J, Bates G (2011) The new science of ageing. Philos. Trans.
R. Soc. Lond. B Biol. Sci. 366, 6–8.
Perheentupa A, Huhtaniemi I (2009) Aging of the human ovary and testis. Mol.
Cell. Endocrinol. 299, 2–13.
Piper MD, Bartke A (2008) Diet and aging. Cell Metab. 8, 99–104.
Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, Sinelnikov I,
Krishnamurthy R, Eisner R, Gautam B, Young N, Xia J, Knox C, Dong E, Huang
P, Hollander Z, Pedersen TL, Smith SR, Bamforth F, Greiner R, McManus B,
Newman JW, Goodfriend T, Wishart DS (2011) The human serum metabolo-
me. PLoS ONE 6, e16957.
Metabolic proﬁles associated with age, Z. Yu et al.
ª 2012 The Authors
Aging Cell ª 2012 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
966Ro ¨misch-Margl W, Prehn C, Bogumil R, Roehring C, Suhre K, Adamski J (2011)
Procedure for tissue sample preparation and metabolite extraction for
high-throughput targeted metabolomics. Metabolomics 8, 133–142.
Simm A, Nass N, Bartling B, Hofmann B, Silber RE, Navarrete Santos A (2008)
Potential biomarkers of ageing. Biol. Chem. 389, 257–265.
Spector TD, Williams FM (2006) The UK Adult Twin Registry (TwinsUK). Twin
Res. Hum. Genet. 9, 899–906.
Szibor M, Holtz J (2003) Mitochondrial ageing. Basic Res. Cardiol. 98, 210–218.
Toth MJ, Tchernof A (2000) Lipid metabolism in the elderly. Eur. J. Clin. Nutr.
54(Suppl 3), S121–S125.
Wang Y, Lawler D, Larson B, Ramadan Z, Kochhar S, Holmes E, Nicholson JK
(2007) Metabonomic investigations of aging and caloric restriction in a
life-long dog study. J. Proteome Res. 6, 1846–1854.
Wichmann HE, Gieger C, Illig T (2005) KORA-gen – resource for population
genetics, controls and a broad spectrum of disease phenotypes. Gesundheit-
swesen 67(Suppl 1), S26–S30.
Wijsman CA, Rozing MP, Streeﬂand TC, le Cessie S, Mooijaart SP, Slagboom PE,
Westendorp RG, Pijl H, van Heemst D (2011) Familial longevity is marked by
enhanced insulin sensitivity. Aging Cell 10, 114–121.
Williams RE, Lenz EM, Lowden JS, Rantalainen M, Wilson ID (2005) The metabo-
nomics of aging and development in the rat: an investigation into the effect
of age on the proﬁle of endogenous metabolites in the urine of male rats
using 1H NMR and HPLC-TOF MS. Mol. BioSyst. 1, 166–175.
Yan SF, D’Agati V, Schmidt AM, Ramasamy R (2007) Receptor for advanced
glycation endproducts (RAGE): a formidable force in the pathogenesis of the
cardiovascular complications of diabetes & aging. Curr. Mol. Med. 7, 699–
710.
Yu Z, Kastenmuller G, He Y, Belcredi P, Moller G, Prehn C, Mendes J, Wahl S,
Roemisch-Margl W, Ceglarek U, Polonikov A, Dahmen N, Prokisch H, Xie L, Li
Y, Wichmann HE, Peters A, Kronenberg F, Suhre K, Adamski J, Illig T, Wang-
Sattler R (2011) Differences between human plasma and serum metabolite
proﬁles. PLoS ONE 6, e21230.
Zhai G, Wang-Sattler R, Hart DJ, Arden NK, Hakim AJ, Illig T, Spector TD (2010)
Serum branched-chain amino acid to histidine ratio: a novel metabolomic
biomarker of knee osteoarthritis. Ann. Rheum. Dis. 69, 1227–1231.
Zhu X, Gallogly MM, Mieyal JJ, Anderson VE, Sayre LM (2009) Covalent cross-
linking of glutathione and carnosine to proteins by 4-oxo-2-nonenal. Chem.
Res. Toxicol. 22, 1050–1059.
Supporting Information
Additional supporting information may be found in the online version of
this article at the publisher’s web-site:
Fig. S1 Correlation matrix for women in KORA F4.
Fig. S2 Heat map of the fold standard deviation changes between ages,
and clustering of these changes over all ages, in 1124 males from KORA
F4.
Fig. S3 Concentration trends of 13 potential biomarkers in women from
KORA F4.
Fig. S4 Concentration trends of 12 selected metabolites in males from
KORA F4.
Fig. S5 Concentration trends of the set of 13 metabolites in women from
the TwinsUK study.
Table S1 Characteristics of 163 metabolites in KORA F4.
Table S2 Potential biomarkers for age in men from KORA F4.
Metabolic proﬁles associated with age, Z. Yu et al.
ª 2012 The Authors
Aging Cell ª 2012 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
967